2022
-
First-ever CPPD classification criteria presented
The proposed criteria, in development since 2019, will help clinicians more accurately diagnose and treat calcium pyrophosphate deposition disease and encourage renewed research into this disease, said Sara K. Tedeschi, MD, MPH, who was one of the co-leaders of the criteria project.
-
New ACR vaccination guideline in press
With the recognition that rheumatic and musculoskeletal diseases (RMDs) and immunosuppression can affect the immunogenicity and safety of vaccines, the ACR has issued its own guideline for vaccination in patients with RMDs. Project leader Anne Bass, MD, and other panelists outlined the new recommendations at…
-
Plenary II details data on biosimilar switching, co-pays, and other new research
The second of three plenary sessions addressed ground-breaking developments in rheumatic diseases, including Sjögren’s syndrome, systemic sclerosis, lupus, and osteoarthritis. Raisa Lomanto Silva, MD, discussed drug co-pay costs and adherence.
-
Rheumatologists can help young patients to preserve their reproductive health
Children with rheumatic disease often become adults with rheumatic disease. Cuoghi Edens, MD, FAAP, and Jacqueline Maher, MD, discussed how rheumatology providers can support reproductive health and protect fertility in adolescent patients.
-
Experts offer guidance on contraception safety, legal risks in reproductive health session
Panelists including Megan Clowse, MD, MPH, offered practical guidance and tools for discussing contraception and family planning with rheumatology patients. She encouraged honest, accurate conversation, as well as creating an environment of trust and safety.
-
Open communication facilitates dignity and respect in care of gender-diverse patients
Many transgender and non-binary patients avoid seeking care because of the discrimination they have faced in the clinic. This lack of care can lead to chronic health issues, said Nathan Levitt, FNP-BC, MSN, RN, BSN, MA, in a session on strategies for improving the clinical…
-
Experts debate the role of DMARDs in subclinical RA
During this year’s Great Debate, experts including Janet Pope, MD, MPH, FRCPC, and Hani El-Gabalawy, MD, FRCPC, reviewed the data on subclinical disease and the risk of progression to rheumatoid arthritis, presenting arguments for and against starting a DMARD in this challenging clinical scenario.
-
Kristin Wipfler, PhD: Impact on Access to Methotrexate in the Post-Roe Era
Kristin Wipfler, PhD, will discuss the poster “Impact on Access to Methotrexate in the Post-Roe Era” in a Monday afternoon Ignite Talk.
-
Matthew C. Baker, MD, MS: Sarcoidosis Incidence after mTOR Inhibitor Treatment
Kristin Wipfler, PhD, will discuss the poster “Impact on Access to Methotrexate in the Post-Roe Era” in a Monday afternoon Ignite Talk.
-
Robert M. Hamilton, MD, MHSc, FRCP(C): Fetal Cardiac Targets Identify the Autoantibodies Associated with Congenital Heart Block
Robert M. Hamilton, MD, MHSc, FRCP(C), will discuss the poster “Fetal Cardiac Targets Identify the Autoantibodies Associated with Congenital Heart Block” in a Monday afternoon Ignite Talk.